Literature DB >> 34185254

People Living with Inflammatory Bowel Disease Want Multidisciplinary Healthcare: A Qualitative Content Analysis.

Meg Feeney1, Anna Chur-Hansen2, Antonina Mikocka-Walus3,4.   

Abstract

This study reports on the preferences of people with inflammatory bowel disease (IBD) for their healthcare. Overall, 477 people with IBD responded to an open-ended survey question within a larger study. We qualitatively content-analysed these responses with open coding using NVivo. Respondents expressed a desire for (1) better communication, (2) multidisciplinary care, (3) better treatment, services and specialist care, (4) whole person care, (5) health promotion, (6) proactive healthcare, (7) fewer administrative issues and (8) improved hospital experience. Patients with IBD want patient-centred, multidisciplinary care. Healthcare professionals should facilitate patients' access to proactive care.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biopsychosocial; Healthcare; Inflammatory bowel disease; Integrated; Multidisciplinary

Mesh:

Year:  2021        PMID: 34185254     DOI: 10.1007/s10880-021-09801-4

Source DB:  PubMed          Journal:  J Clin Psychol Med Settings        ISSN: 1068-9583


  27 in total

1.  Inflammatory Bowel Disease Patient Experiences with Psychotherapy in the Community.

Authors:  Meredith R Craven; Sarah Quinton; Tiffany H Taft
Journal:  J Clin Psychol Med Settings       Date:  2019-06

2.  Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.

Authors:  David J Gracie; Elspeth A Guthrie; P John Hamlin; Alexander C Ford
Journal:  Gastroenterology       Date:  2018-01-31       Impact factor: 22.682

3.  A Multidisciplinary Approach to Biopsychosocial Care for Adults With Inflammatory Bowel Disease: A Pilot Study.

Authors:  Chang Kyun Lee; Gil Y Melmed; Amy Mann; Itai Danovitch; Rebecca Hedrick; Dermot P B McGovern; Stephan Targan; David Shih; Eric Vasiliauskas; Waguih William IsHak; Edward Feldman
Journal:  Inflamm Bowel Dis       Date:  2018-11-29       Impact factor: 5.325

4.  Living with Inflammatory Bowel Disease: A review of qualitative research studies.

Authors:  Simona Fourie; Debra Jackson; Helen Aveyard
Journal:  Int J Nurs Stud       Date:  2018-07-31       Impact factor: 5.837

5.  Food-related quality of life in patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  Livia Guadagnoli; Ece A Mutlu; Bethany Doerfler; Ammoura Ibrahim; Darren Brenner; Tiffany H Taft
Journal:  Qual Life Res       Date:  2019-03-21       Impact factor: 4.147

6.  Personalized Inflammatory Bowel Disease Care Reduced Hospitalizations.

Authors:  Julia J Liu; Thomas Brent Rosson; Jesse J Xie; Zachary P Harris; Regina G McBride; Eric Siegel; Curt Hagedorn
Journal:  Dig Dis Sci       Date:  2019-02-12       Impact factor: 3.487

7.  Seeking control through the determination of diet: a qualitative investigation of women with irritable bowel syndrome and inflammatory bowel disease.

Authors:  Anne E Jamieson; Paula C Fletcher; Margaret A Schneider
Journal:  Clin Nurse Spec       Date:  2007 May-Jun       Impact factor: 1.067

8.  The Pain Experience of Patients Hospitalized With Inflammatory Bowel Disease: A Phenomenological Study.

Authors:  Esther I Bernhofer; V Maria Masina; Jeanne Sorrell; Mary Beth Modic
Journal:  Gastroenterol Nurs       Date:  2017 May/Jun       Impact factor: 0.978

9.  Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women.

Authors:  Eileen M Kesson; Gwen M Allardice; W David George; Harry J G Burns; David S Morrison
Journal:  BMJ       Date:  2012-04-26

10.  The importance of productive patient-professional interaction for the well-being of chronically ill patients.

Authors:  Jane Murray Cramm; Anna Petra Nieboer
Journal:  Qual Life Res       Date:  2014-09-30       Impact factor: 4.147

View more
  1 in total

Review 1.  Re-Routing Infliximab Therapy: Subcutaneous Infliximab Opens a Path Towards Greater Convenience and Clinical Benefit.

Authors:  Rieke Alten; Yoorim An; Dong-Hyeon Kim; SangWook Yoon; Laurent Peyrin-Biroulet
Journal:  Clin Drug Investig       Date:  2022-06-03       Impact factor: 2.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.